Mutations in copper-zinc-superoxide dismutase ( SOD 1 ) are believed to cause ALS in humans and transgenic mice. Researchers found that most of SOD1 in the spinal cord of mouse models of ALS was copper deficient. Treatment with copper ( ATSM ) could provide a therapy for patients with ALS.
Journal of Neuroscience June 4, 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment